Treatment Of Supracondylar Fractures Closed Reduction And Circular Ring External Fixation Versus Open Reduction and Internal Fixation

Sponsor
Baylor College of Medicine (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02196311
Collaborator
(none)
0
1
45
0

Study Details

Study Description

Brief Summary

Patients treated with circular external fixation will have better outcomes (as measured by range of motion (ROM), alignment, outcome surveys) than those treated with open reduction and internal fixation (ORIF).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of this study is to compare patients who undergo ORIF versus circular external fixation for supracondylar humerus fractures in children ages 12-18. We are asking parental permission to collect information about their child's injury, x-rays, obtain ROM measures, collect input from questionnaires, and review other medical information relating to the injury.

    The study is NOT about randomizing subjects to treatment, rather we are asking permission to keep track of the decisions that are made about our population's treatment and how it impacts their recovery.

    The eligibility criteria is subject's between 12 and 18 years, if supracondylar/periarticular humerus fracture needed operative fixation, and the fracture is unable to be treated with percutaneous skeletal fixation. Patients will be excluded if they have had a previous elbow injury, Osteogenesis imperfecta or another fragile bone disease, elbow stiffness from another cause, or any pre-existing arm weakness.

    The outcome measures all enrolled subjects will complete are the QuickDASH and the Pediatric and Adolescent Outcomes Instruments (PODCI). The QuickDASH is a shortened version of the DASH (Disabilities of the Arm, Shoulder and Hand) Outcome Measure which is intended to measure symptoms and functions in people with musculoskeletal disorders of the upper limb. The QuickDASH is valid and reliable and is used for clinical and research purposes. The PODCI is designed to assess patients overall health, pain and ability to participate in normal daily activities in patients under 19 years of age. We will only distribute both questionnaires to the subjects and we are not collecting parent perception.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    TREATMENT OF SUPRACONDYLAR FRACTURES IN ADOLESCENTS: CLOSED REDUCTION AND CIRCULAR RING EXTERNAL FIXATION VERSUS OPEN REDUCTION AND INTERNAL FIXATION
    Actual Study Start Date :
    Mar 1, 2014
    Actual Primary Completion Date :
    Dec 1, 2017
    Actual Study Completion Date :
    Dec 1, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    Supracondylar humerus fractures

    We are looking to compare open reduction internal fixation versus circular external fixation for supracondylar humerus fractures.

    Outcome Measures

    Primary Outcome Measures

    1. Range of motion (ROM), change is being assessed [Initial post-op (first return visit to clinic after surgery), 6 (+/-) weeks, 3(+/-) months, 6 months, 1 year, and 2 years]

      Assessing ROM (elbow flexion/extension) in the initial post-operative period and long-term follow-up is an important outcome measure since it correlated with the ability to perform certain tasks with the arm (e.g. reaching head to shampoo/brush hair, reaching mouth to eat, etc.) The visit time frame as outlined above reflects the visits a child would typically return to clinic after surgery for a supracondylar fracture. Every visit will have a threshold of a few weeks to allow the family to return to clinic. These visits are all after the surgery has been performed. For example, the first or initial visit is the first time the patient will return to the hospital after surgery. At this visit the potential participant will be presented with the study materials and given the opportunity to participate. Should the participant participate the visits in the time frame will occur at the give interval.

    Secondary Outcome Measures

    1. Treatments, change is being assessed [Initial post-op, 6 weeks, 3 months, 6 months, 1 year, and 2 years]

      Evaluating the various treatments for supracondylar humerus fractures, open reduction internal fixation and circular external fixation. The visit time frame as outlined above reflects the visits a child would typically return to clinic after surgery for a supracondylar fracture. Every visit will have a threshold of a few weeks to allow the family to return to clinic. These visits are all after the surgery has been performed. For example, the first or initial visit is the first time the patient will return to the hospital after surgery. At this visit the potential participant will be presented with the study materials and given the opportunity to participate. Should the participant participate the visits in the time frame will occur at the give interval.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 12 and 18 years old

    • Supracondylar/periarticular humerus fracture needed operative fixation

    • Fracture is unable to be treated with percutaneous skeletal fixation.

    Exclusion Criteria:
    • Any previous elbow injury

    • Osteogenesis imperfecta or another fragile bone disease

    • Elbow stiffness from another cause

    • Any pre-existing arm weakness.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Texas Children's Hospital Houston Texas United States 77030

    Sponsors and Collaborators

    • Baylor College of Medicine

    Investigators

    • Principal Investigator: Jaclyn F Hill, MD, Texas Children's Hospital & Baylor College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Jaclyn Hill, Assistant Professor, Baylor College of Medicine
    ClinicalTrials.gov Identifier:
    NCT02196311
    Other Study ID Numbers:
    • H-34336
    First Posted:
    Jul 22, 2014
    Last Update Posted:
    Nov 12, 2020
    Last Verified:
    Nov 1, 2020
    Keywords provided by Jaclyn Hill, Assistant Professor, Baylor College of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 12, 2020